Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 0 shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-05-04
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 247.05K shares, a 44.03% decline from fiscal 2023.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 441.39K shares, a 11.75% decline from fiscal 2022.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 500.15K shares, a 119.07% increase from fiscal 2021.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2021 was 228.30K shares, a 67.56% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-04 | |||
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-03 | 0.00 shares 10-Q · filed 2025-11-03 | 0.00 shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 0.00 shares 10-Q · filed 2025-08-04 | 0.00 shares derived: sum of 3 quarters · filed 2026-02-13 | 71.94K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-05 | 0.00 shares derived: sum of 2 quarters · filed 2026-02-13 | 71.94K shares derived: sum of 3 quarters · filed 2026-02-13 | 88.61K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 71.94K shares derived: sum of 2 quarters · filed 2026-02-13 | 88.61K shares derived: sum of 3 quarters · filed 2026-02-13 | 247.05K shares 10-K · filed 2026-02-13 |
| 2024-09-30 | 71.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | 88.61K shares derived: sum of 2 quarters · filed 2024-11-04 | 247.05K shares 10-Q · filed 2024-11-04 | 278.46K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | 16.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 175.11K shares 10-Q · filed 2024-08-06 | 206.53K shares derived: sum of 3 quarters · filed 2026-02-13 | 248.04K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | 158.44K shares 10-Q · filed 2024-05-07 | 189.85K shares derived: sum of 2 quarters · filed 2026-02-13 | 231.37K shares derived: sum of 3 quarters · filed 2026-02-13 | 285.31K shares derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | 31.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | 72.94K shares derived: sum of 2 quarters · filed 2026-02-13 | 126.88K shares derived: sum of 3 quarters · filed 2026-02-13 | 441.39K shares 10-K · filed 2026-02-13 |
| 2023-09-30 | 41.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 95.46K shares derived: sum of 2 quarters · filed 2023-11-07 | 409.98K shares 10-Q · filed 2023-11-07 | 472.92K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-06-30 | 53.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | 368.46K shares 10-Q · filed 2023-08-01 | 431.40K shares derived: sum of 3 quarters · filed 2025-02-10 | 513.98K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2023-03-31 | 314.52K shares 10-Q · filed 2023-05-02 | 377.46K shares derived: sum of 2 quarters · filed 2025-02-10 | 460.04K shares derived: sum of 3 quarters · filed 2025-02-10 | 533.11K shares derived: sum of 4 quarters · filed 2025-02-10 |
| 2022-12-31 | 62.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-10 | 145.52K shares derived: sum of 2 quarters · filed 2025-02-10 | 218.59K shares derived: sum of 3 quarters · filed 2025-02-10 | 500.15K shares 10-K · filed 2025-02-10 |
| 2022-09-30 | 82.58K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | 155.65K shares derived: sum of 2 quarters · filed 2022-11-01 | 437.20K shares 10-Q · filed 2022-11-01 | 480.66K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-06-30 | 73.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | 354.63K shares 10-Q · filed 2022-08-02 | 398.08K shares derived: sum of 3 quarters · filed 2024-02-09 | 437.44K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2022-03-31 | 281.55K shares 10-Q · filed 2022-05-03 | 325.01K shares derived: sum of 2 quarters · filed 2024-02-09 | 364.37K shares derived: sum of 3 quarters · filed 2024-02-09 | 441.05K shares derived: sum of 4 quarters · filed 2024-02-09 |
| 2021-12-31 | 43.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | 82.82K shares derived: sum of 2 quarters · filed 2024-02-09 | 159.50K shares derived: sum of 3 quarters · filed 2024-02-09 | 228.30K shares 10-K · filed 2024-02-09 |
| 2021-09-30 | 39.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | 116.04K shares derived: sum of 2 quarters · filed 2021-11-02 | 184.84K shares 10-Q · filed 2021-11-02 | 673.99K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-06-30 | 76.68K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 145.48K shares 10-Q · filed 2021-08-03 | 634.63K shares derived: sum of 3 quarters · filed 2023-02-10 | 676.99K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2021-03-31 | 68.80K shares 10-Q · filed 2021-05-04 | 557.95K shares derived: sum of 2 quarters · filed 2023-02-10 | 600.31K shares derived: sum of 3 quarters · filed 2023-02-10 | 705.67K shares derived: sum of 4 quarters · filed 2023-02-10 |
| 2020-12-31 | 489.15K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | 531.51K shares derived: sum of 2 quarters · filed 2023-02-10 | 636.86K shares derived: sum of 3 quarters · filed 2023-02-10 | 703.84K shares 10-K · filed 2023-02-10 |
| 2020-09-30 | 42.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | 147.72K shares derived: sum of 2 quarters · filed 2020-11-02 | 214.69K shares 10-Q · filed 2020-11-02 | 781.11K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 105.36K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 172.33K shares 10-Q · filed 2020-08-04 | 738.75K shares derived: sum of 3 quarters · filed 2022-02-15 | 868.23K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 66.97K shares 10-Q · filed 2020-05-05 | 633.39K shares derived: sum of 2 quarters · filed 2022-02-15 | 762.88K shares derived: sum of 3 quarters · filed 2022-02-15 | 822.68K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 566.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 695.90K shares derived: sum of 2 quarters · filed 2022-02-15 | 755.70K shares derived: sum of 3 quarters · filed 2022-02-15 | 809.45K shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 129.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 189.29K shares derived: sum of 2 quarters · filed 2019-11-05 | 243.04K shares 10-Q · filed 2019-11-05 | 872.54K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | 59.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | 113.55K shares 10-Q · filed 2019-08-06 | 743.05K shares derived: sum of 3 quarters · filed 2021-02-24 | 773.05K shares derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | 53.75K shares 10-Q · filed 2019-05-07 | 683.25K shares derived: sum of 2 quarters · filed 2021-02-24 | 713.25K shares derived: sum of 3 quarters · filed 2021-02-24 | |
| 2018-12-31 | 629.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 659.50K shares derived: sum of 2 quarters · filed 2021-02-24 | 1.01M shares 10-K · filed 2021-02-24 | |
| 2018-09-30 | 30.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 385.06K shares 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | 355.06K shares 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | 721.76K shares 10-K · filed 2020-02-25 | |||
| 2016-12-31 | 120.28K shares 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |